Natriuretic peptides (NPs) are involved in many physiological processes, including regulation of vascular tone, sodium excretion, pressure-volume homeostasis, inflammatory responses and cellular growth. Two main receptors of NP, membrane-bound guanylyl cyclases A and B (GC-A and GC-B), mediate the effects of NP via generation of cGMP. NP-stimulated generation of cGMP can be modulated by intracellular processes, whose exact natures remain to be elucidated. Thus, serum and lysophosphatidic acid (LPA), by unknown pathways, have been shown to inhibit NP-induced generation of cGMP. Here we report that the nonreceptor tyrosine kinase Csk is an essential component of the intracellular modulation of atrial natriuretic peptide (ANP)-stimulated activation of GC-A. Genetic deletion of Csk (Csk −/− ) in mouse embryonic fibroblasts blocked the inhibitory effect of both serum and LPA on ANP-stimulated generation of cGMP. Moreover, using a chemical rescue approach, we also demonstrate that the catalytic activity of Csk is required for its modulatory function. Our data demonstrate that Csk is involved in the control of cGMP levels, and that membrane-bound guanylyl cyclases can be critically modulated by other receptor-initiated intracellular signaling pathways.Many cellular processes such as cell migration, smooth muscle contraction, cellular growth and proliferation are under the control of the second messenger cGMP (1). In eukaryotes, cGMP is synthesized by two distinctive classes of guanylyl cyclases: membrane-bound guanylyl cyclases and soluble guanylyl cyclases (2). Soluble guanylyl cyclases are regulated by intracellular nitric oxide. Among membrane-bound forms, the receptor guanylyl cyclases, GC-A and GC-B, represent the most widely expressed enzymes (3,4). Their activity is primarily regulated through a set of natriuretic peptide hormones, namely atrial natriuretic peptide (ANP), brain type natriuretic peptide (BNP) and C-type natriuretic peptide (CNP) (5,6). GC-A binds both ANP and BNP, while the specific ligand for GC-B is CNP. Binding of natriuretic peptides to the extracellular domains of GC-A and GC-B results in the activation of the receptors to produce cGMP (7). The most well studied physiological role of natriuretic peptides is the maintenance of cardiovascular pressure-volume homeostasis (8,9). Natriuretic peptides lower the blood pressure, increase renal salt excretion, glomerular filtration rate and vascular smooth muscle relaxation, and antagonize all known actions of the renin-angiotensinaldosterone system (8). In addition, natriuretic peptide receptor guanylyl cyclases have attracted a great deal of attention in recent years for their ability to modulate cell proliferation † Supported by grants from the NIH (AG014563 and GM056904). (12,14,15). Moreover, ANP has been shown to inhibit cardiomyocyte hypertrophy induced by growth factors and other stimuli through a cGMP dependent mechanism (16).Both GC-A and GC-B consist of an extracellular ligand binding domain, a short membrane spanning domain, a ki...